7/11/2013

UCB subsidiary Kremers Urban Pharmaceuticals obtained federal approval for its extended-release methylphenidate hydrochloride therapy in the 18 mg and 27 mg strengths. The drug is a generic version of ALZA Corp.'s Concerta.

Full Story:
RTT News

Related Summaries